Biotech - Spark Newswire

1 minute read

Why Shares Of Applied UV Are Trading Higher Today

Today, 10:38 PM

Applied UV (NASDAQ: AUVI) shares are trading higher after the company announced laboratory results confirming the SteriLumen Lumicide Ribbon kills SARS-CoV-2. SteriLumen Lumicide Ribbon is Applied UV's proprietary connected UVC disinfection platform for surface disinfection.

AUVI

2 minute read

Altimmune’s Stock Trades In A Double Bottom Pattern: What’s Next?

By Tyler Bundy

Today, 10:38 PM

Altimmune Inc. (NASDAQ: ALT) shares traded higher after the company announced data from its ALT-801 Phase 1 Trial in overweight and obese volunteers. The company announced that weight loss of 5.4% was achieved at six weeks with a weekly dose of 1.8mg.

ALT

1 minute read

JNJ Unlikely To Meet Q2 COVID-19 Vaccine Supply Target To EU: Reuters

By Vandana Singh

Today, 10:38 PM

Johnson & Johnson (NYSE:JNJ) will miss its COVID-19 vaccine supply target to the European Union for the second quarter after millions…

JNJ

2 minute read

Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today

By Shanthi Rexaline

Today, 10:38 PM

Kindred Biosciences, Inc. (NASDAQ: KIN), Aprea Therapeutics, Inc. (NASDAQ: APRE), Catabasis Pharmaceuticals, Inc.

ABBV

1 minute read

First Patient Set To Receive Biogen’s Alzheimer’s Drug: Reuters

By Vandana Singh

Today, 10:38 PM

A U.S. hospital on Wednesday will give the first infusion of Biogen Inc’s (NASDAQ:BIIB) expensive, controversial Alzheimer’s drug approved a week…

BIIB

1 minute read

Why Shares Of BriaCell Therapeutics Surged Today

By Bill Haddad

Today, 10:38 PM

BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher on Wednesday after the company announced it is expanding its breast cancer platform into prostate, melanoma and lung cancers.

BCTX

2 minute read

Moderna COVID-19 Vaccine Order Flow Abounds As US Strikes Deal For 200M More Doses

By Shanthi Rexaline

Today, 10:38 PM

The U.S.

MRNA

1 minute read

Paratek Launches Mid-Stage NTM Program With Nuzyra, Second Procurement Under BARDA Pact Expected In 2H 2022

By Vandana Singh

Today, 10:38 PM

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) has initiated Phase 2b trial evaluating Nuzyra (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease caused by Mycobacterium…

PRTK

1 minute read

Novo Nordisk, Lumen Bioscience Collaborate For Oral Biologics For Cardiometabolic Diseases

By Vandana Singh

Today, 10:38 PM

Privately-held Lumen Bioscience has entered into a research collaboration with Novo Nordisk A/S (NYSE:NVO) to evaluate the use of Lumen’s spirulina-based drug development and…

NVO

1 minute read

BriaCell Extends Personalized Breast Cancer Immunotherapy To Prostate & Lung Cancer And Melanoma

By Vandana Singh

Today, 10:38 PM

BriaCell Therapeutics Corp (NASDAQ:BCTX) has advanced its targeted oncology therapeutics into several novel immunotherapy cell lines, including – Bria-Pros for prostate…

BCTX